₨ Official DRAP price
PKR 380.12
2x10's
PKR 19.01 / tablet
✓ DRAP listed · Verified 2026-08-08
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 19.01/ tablet
Price position8% below medianvs like-for-like peer median
Peer comparators79current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Losartan
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin II receptor blockers
- ATC
- C09CA01
- Strength
- 50 mg
- Dosage form
- Tablet
- Pack
- 2x10's
- Registration no.
- 035650
- Verification
- 2026-08-08
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 380.12 | 2025-09-04 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
A2A 25 mgWilson's Pharmaceuticals · PKR 334.92A2A 50 mgWilson's Pharmaceuticals · PKR 634.95ACOZAR 25 mgAGP Limited · PKR 221.92ACOZAR 50 mgAGP Limited · PKR 415.22ACOZAR 100 MGAGP Limited · PKR 415.22ACTILOP : 50 mgDe-Mont Research Laboratories (Pvt.) Ltd. · PKR 370.03Angilock 50 mgVENUS PHARMA · PKR 339.50Anglozar 100 mgMartin Dow Marker Limited · PKR 432.45
Price note: Unit-price comparisons are informational calculations from source-listed pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.